Postnatal weight increase and growth velocity of very low birthweight infants

E Bertino1, A Coscia, M Mombrò

  • 1Cattedra di Neonatologia, Dipartimento di Scienze Pediatriche e dell'Adolescenza, Università di Torino, Via Ventimiglia 3, 10126 Torino, Italy. enrico.bertino@unito.it

Insights

Postnatal growth in very low birthweight (VLBW) infants shows two peaks, but those with morbidities or small for gestational age experience impaired growth. This study analyzes VLBW infant growth kinetics up to two years.

Area of Science:

  • Neonatalogy
  • Pediatric Growth and Development
  • Biostatistics

Background:

  • Limited research exists on postnatal growth velocity in very low birthweight (VLBW) infants.
  • Understanding VLBW infant growth patterns is crucial for optimizing care.

Purpose of the Study:

  • To analyze the weight growth kinetics of very low birthweight (VLBW) infants from birth to over two years of age.
  • To establish a growth model for VLBW infants.

Main Methods:

  • 262 VLBW infants were studied, excluding those with major congenital anomalies, necrotising enterocolitis, or significant loss to follow-up.
  • Weight was recorded frequently from birth through 24 months corrected age.
  • Individual growth profiles were modeled using a seven-constant exponential-logistic function.

Main Results:

  • VLBW infants exhibited an early (2-6 weeks) and a late (7-21 weeks) neonatal peak in growth velocity after initial weight loss.
  • Infants who were small for gestational age or had major morbidities showed reduced growth compared to reference VLBW infants.
  • At 2 years, weight differences reached approximately 860g, primarily due to diminished late neonatal peak height in infants with morbidities.

Conclusions:

  • The developed growth model can assess the impact of pathological conditions and care protocols on VLBW infant growth kinetics.
  • This model provides a tool for evaluating interventions aimed at improving VLBW infant growth outcomes.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Rate of Change: Problem Solving01:26

Rate of Change: Problem Solving

Temperature-Dependent Growth of Brook TroutThe growth of brook trout is closely influenced by water temperature. Experimental data demonstrate how trout weight changes over a 24-day period in response to varying water temperatures. At lower temperatures, such as 15.5 degrees Celsius, brook trout show significant weight gain. However, as the temperature increases, the amount of weight gained steadily decreases. At the highest temperature measured, 24.4 degrees Celsius, trout experience a net...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...